换一批Treatment continuation with cladribine at 5 years after initiation in people with multiple sclerosis: A case series and literature review.
第一作者：
Tarunya,Arun
第一单位：
Department of Neurosciences, Level 4 Central Wing, University Hospitals of Coventry and Warwickshire, Clifford Bridge Road, Coventry, CV2 2DX, UK; Warwick Evidence, Warwick Medical School, Gibbet Hill Campus, Coventry, CV4 7AL, UK. Electronic address: tarunya.arun@uhcw.nhs.uk.
作者：
医学主题词
人类(Humans);克利屈滨(Cladribine);女(雌)性(Female);成年人(Adult);男(雄)性(Male);中年人(Middle Aged);多发性硬化, 复发缓解性(Multiple Sclerosis, Relapsing-Remitting);免疫抑制剂(Immunosuppressive Agents)
DOI
10.1016/j.msard.2024.105837
PMID
39180839
发布时间
2025-01-27
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
